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Porphyromonas gingivalis, a periodontal pathogen, expresses a group of surface proteins with a common
C-terminal domain (CTD) that are exported by a novel secretion system to the surface, where they are
covalently attached. Using RgpB as a model CTD protein, we have produced a series of site-directed mutations
in the CTD sequence at conserved residues and at residues that may be modified and, hence, surface attached.
The mutant RgpB proteins were expressed in a P. gingivalis host lacking functional RgpB and RgpA Arg-
specific proteases. The RgpB mutants produced were Y674F, Y674F Y718F, T675Q S679Q T682Q T684Q,
T693Q, F695A, D696A, N698A, G699P, G716P, T724Q, T728Q T730Q, and K732Q and a protein with a deletion
of residues 692 to 702 (692-702). The mutants were characterized for cell-associated Arg-specific protease
activity and for cellular distribution using anti-Rgp antibodies and Western blotting of culture fractions. All
the mutants exhibited cell-associated Arg-specific activity similar to that of the positive control except for the
D696A and 692-702 mutants. For all mutants, except D696A and 692-702, the RgpB proteins were found
modified and attached to the cell surface, which was the same profile found in the positive-control strain. Only
trace amounts of the precursor form of the 692-702 mutant were detected in the outer membrane, with none
detected in the periplasm or culture fluid although cell transcript levels were normal. The results suggest that
residues 692 to 702 of the CTD, in particular, residue D696, have an important role in the attachment of RgpB
at the cell surface and that without attachment secretion does not occur.
Porphyromonas gingivalis is an anaerobic bacterium found in
subgingival dental plaque and has been implicated as a major
pathogen in the initiation and progression of chronic periodon-
titis (3). There is evidence to suggest that individuals with
periodontitis may be more susceptible to cardiovascular dis-
eases (11), and the disease in pregnant women has been linked
to preterm birth and low birth weight of their infants (8, 21).
The cysteine proteinases, called gingipains, are major virulence
factors of P. gingivalis and include the Arg-gingipains (RgpA
and RgpB derived from the genes rgpA and rgpB, respectively)
which are specific for hydrolysis of arginyl peptide bonds, and
Lys-gingipain (Kgp derived from kgp), which is specific for
hydrolysis of lysyl peptide bonds (5, 36). Two protein forms are
derived from rgpB: a soluble discrete enzyme RgpB and a cell
surface-attached form which represents a posttranslationally
modified form of the protein. The surface-attached form of
RgpB contains heterogeneously modified isoforms that mi-
grate as a diffuse band of 70 to 90 kDa on SDS-PAGE (20, 40)
and has been suggested to contain up to 30% carbohydrate (4,
5). In contrast, the soluble RgpB that has a truncated C-
terminal domain (CTD) migrates as a discrete band of 50 kDa
(10).
The outer membrane proteome of P. gingivalis has been
characterized (35, 40), and a common C-terminal domain of
approximately 70 to 80 amino acyl residues in length was iden-
tified in 34 P. gingivalis proteins (35). These CTD sequences
were aligned to reveal a consensus sequence that can be di-
vided into five regions (A to E) (Fig. 1) (35) despite little other
sequence similarity. These proteins were described as the C-
terminal domain sequence-related family (CTD family). Align-
ment of the CTD of these P. gingivalis proteins with the RgpB
CTD revealed that there are several well-conserved amino acid
residues, with just two fully conserved residues (equivalent to
G699 and G716 of RgpB) (Fig. 1) (35). Genetic manipulation
of RgpB to remove the CTD resulted in accumulation of the
precursor form within the periplasmic space and loss of post-
translational modification, surface attachment, and function of
the enzyme (35), suggesting that the CTD is important for
RgpB export through the outer membrane and that modifica-
tion was associated with functional protein export.
More recently, it has been demonstrated that truncation of
the last two RgpB residues (VK) from the C terminus was
sufficient to prevent transit of the RgpB precursor form out of
the periplasm (19). Notably, however, VK is not a conserved
residue pair at the C termini of many other CTD family pro-
teins, occurring only in the CTD of the closely related HagA
and Kgp (Fig. 1). The recombinant RgpB precursor polypep-
tide lacking VK was inactive and lacked the posttranslational
modification seen in wild-type surface-attached RgpB (19).
Again, these results show that modification is associated with
functional export of RgpB.
Monoclonal antibody (MAb) 1B5 has been shown to recog-
nize modified (surface-attached) RgpB but not the C-termi-
nally truncated soluble form of the protein found in the culture
supernatant, which lacks the CTD (5, 6). Recently, Paramonov
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et al. (25) identified the MAb 1B5 epitope as a phosphorylated
branched mannan (Man1-2Man1-phosphate), which is also
a component of a novel anionic lipopolysaccharide (A-LPS) of
P. gingivalis. The basic structure of LPS is lipid A covalently
linked to a core oligosaccharide, which is further linked to a
polysaccharide comprising repeating units. Two different poly-
saccharides have been characterized in P. gingivalis LPS, des-
ignated O-LPS and A-LPS. O-LPS contains O-polysaccharide
(O-antigen) tetrasaccharide repeating units (24, 26), whereas
A-LPS contains anionic polysaccharide (APS) repeating units
of phosphorylated branched mannan (25, 29). The epitope
recognized by MAb 1B5 was localized to the Man1-2Man1-
phosphate side chain in APS and is not present in O-LPS or
capsule polysaccharide (25).
The increase in the molecular weight (MW) and diffuse
nature of the modified RgpB protein on SDS-PAGE gels is
consistent with a glycolipid modification such as LPS. This,
together with MAb 1B5 recognizing A-LPS, has led to the
suggestion that the CTD of RgpB is essential not only for outer
membrane export but also for covalent attachment to the cell
surface A-LPS anchor (27). Interestingly, MAb 1B5 also binds
to other CTD-containing proteins, namely, RgpAA4 (one of
four related RgpA adhesins), P59 (PG2102), and P27
(PG1795), indicating that these proteins also have Man1-
2Man1-phosphate-associated modifications (40). Hence,
based on this reactivity with MAb 1B5, it has been proposed
that the CTD proteins are covalently attached to A-LPS on the
cell surface through a modified CTD (27). Peptide mass fin-
gerprinting (PMF) analyses of the mature forms of these pro-
teins has not identified any peptide from the CTDs (35, 40),
which may be because the modification blocks identification
and/or because the CTD, upon secretion, is cleaved either
when or before the protein is covalently attached to A-LPS.
The CTD is also present in proteins from a range of bacteria in
the Bacteroidetes phylum, and the proteins that have been
characterized are also attached to the cell surface (9, 39, 41).
These results suggest that the CTD is a component of a unique
protein secretion and cell surface attachment system in a range
of pathogenic bacteria.
To further investigate the function of specific residues of the
CTD in protein export and surface attachment through poten-
tial sites of O- and N-linked modification, we have created a
series of site-directed mutants and a motif B (Fig. 1) deletion
mutant within the RgpB CTD and investigated the cellular
distribution of these recombinant RgpB (rRgpB) mutant pro-
teins. We show that although substitution of most residues had
no effect on rRgpB activity, a D696A mutation and a motif B
(residues 692 to 702) deletion mutation abolished secretion
and surface attachment of the protein.
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. Bacterial strains and plas-
mids used in this study are listed in Table 1. P. gingivalis strains were grown as
described previously (35). P. gingivalis allele exchange mutants were selected on
horse blood agar (HBA; Oxoid, Basingstoke, United Kingdom) plates in the
presence of 10 g ml1 erythromycin and 10 g ml1 chloramphenicol. Subse-
quently, brain heart infusion (BHI; Oxoid) broth cultures were supplemented
with 5 g ml1 erythromycin and 5 g ml1 chloramphenicol. Escherichia coli
strains were grown aerobically at 37°C on Luria-Bertani (LB) agar or in LB broth
supplemented with 100 g ml1 ampicillin.
Electroporation of P. gingivalis. Electroporation-competent P. gingivalis cells
were prepared as follows. An overnight-grown starter culture (1.5 ml) of P.
gingivalis was inoculated into 200 ml of BHI broth and incubated overnight to an
optical density at 650 nm (OD650) of 0.3 to 0.7. Cells were then centrifuged (at
8,000  g for 20 min at 4°C), and the pellet was washed in 200 ml of ice-cold
electroporation buffer (EP buffer; 10% [vol/vol] glycerol, 1 mM MgCl2). The cells
were then centrifuged (at 8,000  g for 20 min at 4°C), and the pellet was
suspended in 400 l of ice-cold EP buffer. Cells (80 l) were aliquoted to cold
microcentrifuge tubes, and 300 to 800 ng of linearized plasmid was added; the
mixture was then incubated on ice for 5 min before being transferred into a
0.1-cm gap cuvette (E. coli pulser cuvette; Bio-Rad Laboratories Inc., CA) and
electroporated at 1.8 kV, with a capacitance of 25 F and resistance of 200 .
One ml of BHI broth containing 5 g ml1 hemin and 0.5 mg ml1 cysteine was
added, and cells were incubated overnight anaerobically before selection of
transformants on HBA plates containing 10 g ml1 erythromycin or 10 g ml1
erythromycin and 5 g ml1 chloramphenicol, as appropriate, with anaerobic
incubation at 37°C for up to 10 days.
FIG. 1. Alignment of the C termini of experimentally identified P. gingivalis proteins with homology to the RgpB C terminus. The sequences
are described using TIGR annotation, with PG0506 representing RgpB. The CTD is divided into five regions designated with the letters A to E
above the alignment. The black shading indicates identical residues (40% identity), light gray shading indicates nonpolar substitutions (A, V, F,
P, M, I, L, W, and Y), and dark gray shading indicates polar (S, T, Y, H, C, N, G, and Q), acidic (D and E), or basic (R and K) substitutions.
Residues that do not have 40% identity but have 70% conservative substitutions are also shaded.
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Construction of P. gingivalis RgpB CTD site-directed mutants. The various
plasmids produced in the course of this work are described in Table 1, the amino
acids within the RgpB CTD that were subject to mutation or deletion are shown
in Fig. 2, and an overview of the recombination strategy is shown in Fig. 3.
P. gingivalis W50AB (40) has rgpA and rgpB inactivated by the insertion of cat
(chloramphenicol resistance cassette) and tetQ (tetracycline resistance cassette),
respectively. The tetQ cassette was selected as the homologous recombination
target for the insertion of recombinant rgpB into the P. gingivalis W50AB chro-
mosome. The recombination cassette to be used, pKTERM1, was generated as
follows: tetQ was excised from pNJR12 (16) using EcoICRI digestion and ligated
into the SmaI site of pUC18, generating plasmid pUCtetQ. The ermF gene
(erythromycin resistance) was excised from pAL30 (7) using EcoICRI and SacII,
blunt ends were generated using T4 DNA polymerase, and the insert was ligated
into EcoRV-digested pUCtetQ. The resultant recombinant plasmid in which
ermF was in the same orientation as tetQ was designated pKTERM1.
A QuikChange II site-directed mutagenesis kit (Stratagene) was employed to
produce a series of plasmids encoding rRgpBs with CTD mutations, using
pBH1.1 as a template and the various primers listed in Table 2. The encoded
mutations were the following: Y674F, Y674F Y718F, T675Q S679Q T682Q
T684Q (termed TSTT), T693Q, F695A, D696A, N698A, G699P, G716P, T724Q,
T728Q T730Q, K732Q, and K732Q (Fig. 2). Each mutated rgpB gene was fully
sequenced to confirm that only the desired mutations were generated. A 2.7-kbp
TABLE 1. Bacterial strains and plasmids
Plasmid or strain Descriptiona Reference or source
Plasmids
pAL30 ermF ligated into pGem-TEasy 7
pBH1.1 pGem-TEasy::rgpB (nt 493-3166) 20
pUCtetQ pUC18::tetQ This study
pJY674F pBH1.1-rgpB(Y674F) This study
pJY674Y718F pBH1.1-rgpB(Y674F Y718F) This study
pJD696A pBH1.1-rgpB(D696A) This study
pKTG699P pBH1.1-rgpB(G699P) This study
pKTG716P pBH1.1-rgpB(G716P) This study
pKTK732Q pBH1.1-rgpB(K732A) This study
pKTT728QT730Q pBH1.1-rgpB(T728Q T730Q) This study
pKTTSTT pBH1.1-rgpB(T675Q S679Q T682Q T684Q) This study
pKTT724Q pBH1.1-rgpB(T724Q) This study
pKTERM1 pUCtetQ::ermF This study
pKTG6 pKTERM1::rgpB(G699P) This study
pKTG7 pKTERM1::rgpB(G716P) This study
pKTK1 pKTERM1::rgpB(K732Q) This study
pKTTT1 pKTERM1::rgpB(T728Q T730Q) This study
pKTB1 pKTERM1::rgpB (nt 493-3166) This study
pKTY1 pKTERM1::rgpB(Y674F) This study
pKTD1 pKTERM1::rgpB(D696A) This study
pKTYY pKTERM1::rgpB(Y674F Y718F) This study
pKTTSTT pKTERM1::rgpB(T675Q S679Q T682Q T684Q) This study
pKTT pKTERM1::rgpB(T724Q) This study
pCM1 pGem-TEasy::rgpB (nt 493-2961)-SfoI This study
pCM2 pCM1::rgpB (nt 3015-3166) This study
pCM3 pKTERM::rgpB(692-702) This study
pCMT693Q pKTERM1::rgpB(T693Q) This study
pCMF695A pKTERM1::rgpB(F695A) This study
pCMN698A pKTERM1::rgpB(N698A) This study
pAL34 934-bp 5-prime fragment of pg0553 ligated between ApaI and AatII sites of pAL30 This study
pAL34.1 1,122-bp 3-prime fragment of pg0553 ligated between SpeI and SalI sites of pAL34 This study
P. gingivalis strains
W50AB W50 rgpA::cat rgpB::tetQ; Cmr Tcr 40
W50AB-Pos W50 rgpA::cat rgpB::tetQ::rgpB; Cmr Emr This study
W50AB-Neg W50 rgpA::cat rgpB::tetQ::ermF; Cmr Emr This study
W50AB-G699P W50 rgpA::cat rgpB::tetQ::ermF-rgpB(G699P); Cmr Emr This study
W50AB-G716P W50 rgpA::cat rgpB::tetQ::ermF-rgpB(G716P); Cmr Emr This study
W50AB-K732Q W50 rgpA::cat rgpB::tetQ::ermF-rgpB(K732P); Cmr Emr This study
W50AB-T728T730Q W50 rgpA::cat rgpB::tetQ::ermF-rgpB(T728Q T730Q); Cmr Emr This study
W50AB-D696A W50 rgpA::cat rgpB::tetQ::ermF-rgpB(D696A); Cmr Emr This study
W50AB-Y674F W50 rgpA::cat rgpB::tetQ::ermF-rgpB(Y674F); Cmr Emr This study
W50AB-Y674Y718F W50 rgpA::cat rgpB::tetQ::ermF-rgpB(Y674F Y718F); Cmr Emr This study
W50AB-T724Q W50 rgpA::cat rgpB::tetQ::ermF-rgpB(T724Q); Cmr Emr This study
W50AB-TSTT W50 rgpA::cat rgpB::tetQ::ermF-rgpB(T675Q S679Q T682Q T684Q); Cmr Emr This study
W50AB-T693Q W50 rgpA::cat rgpB::tetQ::ermF-rgpB(T693Q); Cmr Emr This study
W50AB-F695A W50 rgpA::cat rgpB::tetQ::ermF-rgpB(F695A); Cmr Emr This study
W50AB-N698A W50 rgpA::cat rgpB::tetQ::ermF-rgpB(N698A); Cmr Emr This study
W50AB-692-702 W50 rgpA::cat rgpB::tetQ::ermF-rgpB(692-702); Cmr Emr This study
ECR179 E. coli JM109, pAL34 This study
ECR179.1 E. coli JM109, pAL34.1 This study
ECR190 P. gingivalis W50 pg0553::ermF This study
a Tcr, tetracycline resistance; Cmr, chloramphenicol resistance; Emr, erythromycin resistance. Nucleotides (nt) are numbered according to GenBank accession
number AF007124.
134 SLAKESKI ET AL. J. BACTERIOL.
 o
n
 O
ctober 14, 2015 by University of Queensland Library
http://jb.asm.org/
D
ow
nloaded from
 
fragment containing rgpB was excised from each mutated plasmid and pBH1.1
using NotI digestion and ligated to NotI-digested pKTERM1 (Table 1; Fig. 3).
Recombinant plasmids (Table 1) in which the rgpB genes were in the reverse
orientation to tetQ and ermF were used to transform P. gingivalis. The cassettes
were introduced into P. gingivalis W50AB by electroporation for allele exchange
with tetQ (schematically represented in Fig. 3) with transformants selected on
HBA plates supplemented with erythromycin and chloramphenicol. The positive
control (W50AB-Pos) had rgpB of wild-type sequence and ermF inserted into
tetQ, while the negative control (W50AB-Neg) had only ermF inserted into tetQ.
All P. gingivalis allele exchanges were confirmed by testing for tetracycline sen-
sitivity and by extensive PCR analysis. Only those constructs in which the orien-
tation of rgpB was opposite to that of ermF were used for further analyses in
order to eliminate the possibility of differential polar effects on rgpB expression.
Construction of P. gingivalis RgpB(692–702) deletion mutant. Nucleotides
encoding amino acids (aa) 692 to 702 (LTIFDMNGRRV) (Fig. 2) were deleted
from rgpB using the following stepwise strategy. The primers dmngrRevCM and
M13 universal forward (Table 2) were used to amplify a 2.7-kbp region of
pBH1.1, containing rgpB nucleotides 493 to 2981 in the GenBank entry
AF007124, and the amplicon was ligated to pGEM-TEasy (Promega). An SfoI
restriction site was engineered into the construct at the 3 junction of the rgpB
codons and the multiple-cloning site using site-directed mutagenesis (as previ-
ously described) with dmngrForSfoI and dmngrRevSfoI to produce pCM1. Nu-
cleotides 3015 to 3166 of rgpB (encoding 34 C-terminal amino acids and 3
flanking regions) were then amplified as part of a 250-bp amplicon by PCR using
pBH1.1 template and oligonucleotides dmngrForCM and M13 universal reverse.
The PCR amplicon was treated with T4 DNA polymerase and then digested with
NsiI and ligated to SfoI-NsiI-digested pCM1, producing pCM2. The mutated
rgpB gene was then excised from pCM2 using AatII and NsiI digestion and
ligated to AatII/NsiI-digested pKTERM1, producing pCM3. Following nucleo-
tide sequencing to confirm integrity, pCM3 DNA was electroporated into P.
gingivalis, with recombinants isolated as outlined above.
Construction of P. gingivalis W50 PG0553 isogenic mutant. To make the
pg0553 inactivation cassette, a 934-nucleotide 5 region of pg0553 of P. gingivalis
W50 was PCR amplified using Pfu DNA polymerase (Promega, Madison, WI)
and primer pair PG0553-AatII-For (TCCGATGACGTCGTTGCCACGGAAG
ATGGCC) and PG0553-ApaI-Rev (CAAATCGGGCCCGCAGTCAGGACTG
GCTGC). The amplicon was digested with AatII and ApaI and then ligated 3 to
ermF in AatII- and ApaI-digested pAL30 (7) to produce pAL34 (Table 1). A
1,122-nucleotide 3 region of pg0553 was then PCR amplified using PG0553-
SalI-For2 (AATTGAGTCGACACCATGTTCCGGCCTGCCA) and PG0553-
SpeI-Rev2 (AACGATACTAGTCCTCTGCGCTATCGTGTCT) digested with
SalI and SpeI and ligated 5 to ermF in SalI-SpeI-digested pAL34 to produce
pAL34.1 (Table 1). Plasmid pAL34.1 was linearized with ScaI and transformed
into P. gingivalis strain W50 with recombinants selected on HBA plates supple-
mented with 10 g ml1 erythromycin. Confirmation of DNA integration was
performed by PCR using the primer pairs PG0553KO-For (GCAGTCAGGAC
TGGCTGCC) and PG0553KO-Rev (CGGAGGGAGTTGTCACCTTC). This
created the P. gingivalis W50 PG0553 isogenic mutant (ECR190) (Table 1).
P. gingivalis cell fraction preparation. P. gingivalis cells grown in BHI broth (40
ml) were harvested at an OD650 of 0.61 (cell density of 2.5  109 cells per ml) by
centrifugation (8,000  g for 20 min at 4°C). The supernatant was retained, and
the pellet was suspended in 4 ml of TC150 buffer (50 mM Tris-Cl, pH 8.0, 150
mM NaCl, 5 mM CaCl2, 20 mM cysteine-HCl). An aliquot of the cells (2 ml) was
centrifuged, and the pellet was collected, suspended in 200 l of TC150 buffer in
the presence of 10 mM N-p-tosyl-L-lysine-chloromethyl ketone (TLCK; Sigma),
and stored at 70°C for later use in Western immunoassays. Culture superna-
tants were subjected to ultracentrifugation (300,000  g for 30 min) to pellet
outer membrane vesicles, and the clarified supernatant was retained. For West-
ern blotting the proteins in 2 ml of supernatant were precipitated using 10%
(vol/vol) trichloroacetic acid (TCA) (35) and suspended in 15 l of loading dye.
P. gingivalis Sarkosyl-insoluble outer membranes and TCA-precipitated periplas-
mic protein fractions were prepared as previously described (35).
Arginine amidolytic activity assay. Whole cells (108 in 20 l) plus 340 l of
TC150 buffer or 360 l of vesicle-free supernatant were assayed for Arg-X
amidolytic activity using N-benzoyl-DL-arginine-p-nitroanilide (BApNA; Sigma)
as previously described (35) using a temperature-controlled Cary 50 Bio UV-
visible spectrophotometer (Varian Australia Pty Ltd., Victoria, Australia).
BApNA assays were performed on triplicate samples from three separate cul-
tures, and activity is expressed as mol of BApNA/min/1011 cells.
Western blot analyses. Proteins of whole cells, outer membrane preparations,
concentrated culture supernatant (5 l), and periplasmic preparations were
subjected to SDS-PAGE using NuPAGE Novex Bis-Tris gels (Invitrogen Cor-
poration) and 1 NuPAGE morpholinepropanesulfonic acid (MOPS)-SDS run-
ning buffer, following the manufacturer’s instructions, with the SeeBlue Plus2
prestained protein standard (Invitrogen Corporation). Gels were stained using
Coomassie blue R250 (Bio-Rad, Hercules, CA) or SYPRO Ruby (Molecular
FIG. 2. Site-directed and deletion mutagenesis map of the RgpB CTD. Arrows point to the sites of mutation, with the amino acid changes
indicated. Double and quadruple mutations are indicated by joined arrows. Numbering is from the rgpB primary translation. Amino acids 692 to
702 (boxed) were deleted in the W50AB-692–702 mutant.
FIG. 3. Introduction of recombinant rgpB into P. gingivalis by allele
exchange. In step 1, wild-type sequence (rgpB) or mutated rgpB (rgpB*)
was excised from pBH1.1-based plasmids by NotI digestion and ligated
into the NotI site of pKTERM1. In step 2, the cassette was linearized
and electroporated into P. gingivalis W50AB to allow double-crossover
recombination events. Horizontal arrows indicate open reading frames
and their orientations. The name of each gene is indicated below the
arrow. tetQ, tetracycline resistance-encoding gene; ermF, erythromycin
resistance gene; rgpB, arginine gingipain B gene.
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Probes Inc., Eugene, OR), or proteins were electrotransferred onto nitrocellu-
lose membranes. Membranes were blocked and probed with anti-rRgpAcat
(where RgpAcat indicates the catalytic domain of RgpA) mouse antibodies (anti-
Rgp antibodies) diluted 1 in 500 in TNT buffer (25 mM Tris-HCl [pH 7.5], 500
mM NaCl, 0.1% [vol/vol] Triton X-100) as described previously (35). The im-
munoreactive proteins were detected using SuperSignal West Pico substrate
chemiluminescence (Pierce Biotechnology, Inc., Rockford, U. S. A.) and a Las
3000 instrument (Fujifilm) for image capture.
Protein identification. Proteins were identified in SDS-PAGE gels using in-gel
digestion and mass spectrometry (MS) using matrix-assisted laser desorption
ionization–two-stage time of flight mass spectrometry (MALDI-TOF/TOF MS)
as described previously (18). MS spectra were used to search a P. gingivalis
protein sequence database for protein identification, as described previously
(40).
Statistical analysis. Arg-specific proteolytic activities as measured using
BApNA as a substrate were statistically analyzed using one-way analysis of
variance (ANOVA) with a Scheffe a posteriori multiple comparison using an
SPSS statistical software program (version 17; Chicago, IL).
RESULTS
Generation of site-directed mutations of the RgpB CTD. To
investigate the possible role of specific residues of the CTD of
TABLE 2. Oligonucleotide primers used to construct CTD mutation(s) in rgpBa
Primer name Sequence (533) Primerlocation (nt)b Description
M13 universal forward TGTAAAACGACGGCCAGT
M13 universal reverse CAGGAAACAGCTATGACC
dmngrForSfoI GTCCTGCTGCCGGCGCCGAGAGCTCCCAACGCG 2968–2978 rgpB (nt 2986–2978)-SfoI-
pGemTEasy (nt 103–118)
dmngrRevSfoI CGCGTTGGGAGCTCTCGGCGCCGGCAGCAGGAC 2978–2968 Reverse complement of
dmngrForSfoI
dmngrRevCM CCCGGCAGCAGGACTTTCTAC 2981–2961 rgpB (nt 2981–2961)
dmngrForCM GCTACTGCTAAAAACCGCATGGTATTC 3015–3041 rgpB (nt 3015–3041)
Gly699Profor CTGACGATCTTCGATATGAACCCCCGTCGTGTAGCTAC 2982–3019 RgpB with Gly699 3 Pro
Gly699Prorev GTAGCTACACGACGGGGGTTCATATCGAAGATCGTCAG 3019–2982 Reverse complement of
Gly699Profor
Gly716Profor GAAGCACAAAACCCTGTGTATGCCGTTCG 3042–3070 RgpB with Gly716 3 Pro
Gly716Prorev CGAACGGCATACACAGGGTTTTGTGCTTC 3070–3042 Reverse complement of
Gly716Profor
HSMUT2for ATCGCTCAAGAAGGCAAGCAGTATCAAGAAGTTATAGTG 3072–3113 RgpB with Thr728 3 Gln
and Thr730 3 Gln
HSMUT2rev CACTATAACCTTTTCTTGATACTGCTTGCCTTCTTGAGCGAT 3113–3072 Reverse complement of
HSMUT2for
HSMUT3for GGCAAGACGTATACAGAACAGGTTATAGTGAAGTAATTC 3084–3122 RgpB with Lys732 3 Gln
HSMUT3rev GAATTACTTCACTATAACCTGTTCTGTATACGTCTTGCC 3122–3084 Reverse complement of
HSMUT3for
S679T684for CTGTAGCTGTACAAGGTAAGACGATACAAGTAGAAAGTCC
TGCTG
2932–2976 RgpB with Ser679 3 Gln
and Thr684 3 Gln
S679T684rev CAGCAGGACTTTCTACTTGTATCGTCTTACCTTGTACAGCT
ACAG
2976–2932 Reverse complement of
S679T684for
T675T682for GATAAGCCTTATCAAGTAGCTGTACAAGGTAAGCAGATAC
AAGTAGAAAGTC
2919–2970 RgpB with Thr675 3 Gln
and Thr682 3 Gln
T675T682rev GACTTTCTACTTGTATCTGCTTACCTTGTACAGCTACTTGAT
AAGGCTTATC
2970–2919 Reverse complement of
T675T682for
T724Q-kt-for GCCGTTCGCATCGCTCAAGAAGGCAAGACGTATAC 3063–3097 RgpB with Thr724 3 Gln
T724Q-kt-rev GTATACGTCTTGCCTTCTTGAGCGATGCGAACGGC 3097–3063 Reverse complement of
T724Q-kt-for
RgpBD696A-for GGCTGACGATCTTCGCTATGAACGGCCGTCG 2980–3010 RgpB with Asp696 3 Ala
RgpBD696A-rev CGACGGCCGTTCATAGCGAAGATCGTCAGCC 3010–2980 Reverse complement of
RgpBD696A-for
RgpBY718F-for CACAAAACGGCGTGTTTGCCGTTCGCATCGC 3046–3076 RgpB with Tyr718 3 Phe
RgpBY718F-rev GCGATGCGAACGGCAAACACGCCGTTTTGTG 3076–3046 Reverse complement of
RgpBY718F-for
RgpBY674F-for CGTAGCCAATGATAAGCCTTTTACTGTAGCTGTATCAGG 2909–2947 RgpB with Tyr674 3 Phe
RgpBY674F-rev CCTGATACAGCTACAGTAAAAGGCTTATCATTGGCTACG 2947–2909 Reverse complement of
RgpBY674F-for
RgpBT693Qfor CCTGCTGCCGGGCTGCAAATCTTCGATATG 2970–2999 RgpB with Thr693 3 Gln
RgpBT693Qrev CATATCGAAGATTTGCAGCCCGGCAGCAGG 2999–2970 Reverse complement of
RgpBT693Qfor
RgpBF695Afor CCGGGCTGACGATCGCAGATATGAACGGCCG 2977–3007 RgpB with Phe695 3 Ala
RgpBF695Arev CGGCCGTTCATATCTGCGATCGTCAGCCCGG 3007–2977 Reverse complement of
RgpBF695Afor
RgpBN698Afor CGATCTTCGATATGGCCGGCCGTCGTGTAGC 2986–3016 RgpB with Asn698 3 Ala
RgpBN698Arev GCTACACGACGGCCGGCCATATCGAAGATCG 3016–2986 Reverse complement of
RgpBN698Afor
a All the primers were purchased from GeneWorks, Pty. Ltd., Australia.
b Primer alignment location in rgpB of P. gingivalis W50 according to the rgpB sequence of GenBank accession number AF007124. nt, nucleotides.
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RgpB in the secretion and cell surface attachment of the pro-
tein, residues within the RgpB CTD were mutated by site-
directed mutagenesis or deletion, and the rRgpBs produced in
P. gingivalis were characterized for Arg-X amidolytic activity
and by Western blotting using anti-Rgp antibodies. Thirteen
rRgpBs with CTD mutations were produced: Y674F, Y674F
Y718F, T675Q S679Q T682Q T684Q (termed TSTT), T693Q,
F695A, D696A, N698A, G699P, G716P, T724Q, T728Q
T730Q, and K732Q and a mutant with a deletion of residues
692 to 702 (692–702) (Fig. 2). RgpB residues Y674 and Y718
are reasonably conserved in the CTD sequences and, hence,
were mutated to the structurally conservative phenylalanine to
investigate whether they are involved in O-linked modification.
The eight Ser/Thr residues were mutated in four separate
mutants. Ser/Thr residues of the N-terminal cluster were tar-
geted in the same mutant in RgpB(T675Q S679Q T682Q
T684Q), and the other Thr residues were mutated in
RgpB(T693Q), RgpB(T724Q), and RgpB(T728Q T730Q) in
order to investigate whether these residues are potential sites
for O-linked modification.
Alignment of the RgpB CTD with CTD sequences of other
CTD family proteins revealed that RgpB D696, G699, G716,
and K732 are highly conserved residues (Fig. 1) (35), and thus
these were also targeted for mutation in this study. D696 was
mutated to alanine, and K732 was mutated to glutamine to test
the role of residue polarity and charge, respectively, on secre-
tion and attachment. The conserved RgpB G699 and G716
residues may play a role in the conformational stability of the
CTD; therefore, these residues were mutated to proline in an
attempt to perturb CTD structure.
Analysis of RgpB mutants. (i) Arginine amidolytic activity.
No Arg-X amidolytic activity could be detected in clarified,
unconcentrated culture supernatants of any of the strains, in-
cluding the positive control (W50AB-Pos) expressing the wild-
type RgpB enzyme. In contrast, all strains exhibited measur-
able whole-cell Arg-X amidolytic activity except for the D696A
and 692–702 mutants, where no activity could be detected.
The whole-cell Arg-X amidolytic activity of the W50 positive
control (W50AB-Pos) was 4.7 	 0.3 mol of BApNA/min/1011
cells, and the whole-cell activities of the mutants Y674F,
Y674F Y718F, T675Q S679Q T682Q T684Q, T693Q, F695A,
N698A, G699P, G716P, T724Q, T728Q T730Q, and K732Q
were not significantly different from the activity of W50AB-Pos.
(ii) Cellular distribution and modification of RgpB mutants.
To assess the cellular distribution and modification of the
CTD-mutated RgpB proteins, outer membrane, periplasmic
protein fractions, clarified supernatant, and whole-cell lysates
of the recombinant strains were subjected to SDS-PAGE and
Western blot analyses using anti-Rgp antibodies. Western blot
analysis of outer membrane fractions of all RgpB CTD mutant
strains using the anti-Rgp antibodies showed that the charac-
teristic diffuse band at 70 to 90 kDa, corresponding to modified
RgpB (cell surface-attached isoform), was readily observed in
all RgpB CTD mutant strains except for the motif B deletion
mutant RgpB(692–702), the RgpB(D696A) mutant, and the
negative-control strain W50AB-Neg (Fig. 4, 5, and 6). In mu-
tant 692-702 the Western blot of the outer membrane frac-
tion revealed a trace amount of a single band of 80 kDa,
corresponding to the size of the unprocessed precursor form of
the mutated RgpB containing the prodomain, catalytic do-
main, and mutated CTD (Fig. 5). Repeated Western blotting
of outer membrane preparations of the Y674F, Y674F Y718F,
T675Q S679Q T682Q T684Q, T693Q, F695A, N698A, G699P,
G716P, T724Q, T728Q T730Q, and K732Q mutants and the
positive control (W50AB-Pos) indicated no significant differ-
ences in the intensities of the 70- to 90-kDa (cell surface
attached) RgpB isoform. Western blots of clarified, concen-
trated supernatant proteins showed similar profiles, with all
strains except the 692-702, D696A, and W50AB-Neg strains
producing trace amounts of a 50-kDa fully processed form of
RgpB in the clarified and concentrated culture supernatant
(Fig. 5, 6, and 7). The preparations used for Fig. 5 and 6 were
FIG. 4. Western blot analyses of outer membrane proteins of P. gingivalis allele exchange mutants probed with anti-Rgp. (A) Western blot.
(B) The corresponding SDS-PAGE gel stained with Coomassie blue. Pos, positive control (wild-type sequence RgpB); Neg, negative control. Other
recombinant RgpB proteins are indicated by their mutations.
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contaminated with membrane vesicles so that the membrane-
attached isoform (70- to 90-kDa band) was also present in the
culture supernatant samples. Repeated Western blotting
showed no significant differences between the intensities of the
50-kDa RgpB isoform of the positive control and that of any of
the mutants except for 692-702 and D696A. Western blots of
periplasmic-enriched protein fractions showed no accumula-
tion of mutated RgpB in the periplasm of the 692-702 mutant
(Fig. 5) or D696A mutant (data not shown).
In the protein profiles of the culture supernatants of the
negative control and the 692-702 and D696A mutants, a
prominent band of approximately 63 kDa appeared that was
not present in any of the other strains tested that contained
RgpB active enzyme (Fig. 7A; also data not shown). These
bands were excised from the gel, digested with trypsin, and
analyzed by MALDI-TOF/TOF mass spectrometry. Peptide
mass fingerprinting (PMF) indicated that the major protein
present in the bands from the three strains was PG0553 (Table
3). This assignment was verified by tandem MS (MS/MS) of
four of the observed peptides (Table 3). One of these peptides
(m/z 1,494) could not be identified using the default parame-
ters; however, it matched the peptide QISFGGEPLSFSSR
with the N-terminal glutamine converted to pyroglutamine.
This glutamine is the predicted N terminus of the protein after
removal of the signal peptide. Mass spectrometric analysis of
this protein revealed that it was a C-terminally truncated form
of PG0553 (a predicted endopeptidase) (Table 3).
To investigate the link between PG0553 and RgpB process-
ing and activity, a P. gingivalis W50 pg0553 isogenic mutant was
constructed. The disruption of pg0553 was confirmed using
PCR (data not shown). The Arg-X amidolytic cell surface
activity of the P. gingivalis W50 pg0553 mutant (ECR190) was
not significantly different from that of the W50 wild type.
Furthermore, RgpB was present as the cell-attached 70- to
90-kDa isoform in the PG0553 mutant, indicating that the
PG0553 protein was not essential for secretion and attachment
of RgpB.
Western blotting was repeated for all culture/cell fractions of
the 692-702 and D696A mutants, including whole cell, inner
and outer membrane preparations, and periplasmic and cul-
ture fluid fractions; however, RgpB could not be detected in
any fraction. To eliminate the possibility of a secondary muta-
tion elsewhere in the cell causing the 692-702 and D696A
phenotype, a second mutant strain for each was generated by
transformation of the background strain W50AB once again
with pCM3 and pJD696A, respectively. The phenotype of de-
pressed Rgp(692-702) and RgpB(D696A) production was re-
produced in the second mutants (data not shown), and so the
rgpB(692-702) and rgpB(D696A) recombinant loci were am-
plified by PCR and subjected to DNA sequencing, whereupon
no errors in nucleotide sequences were detected. To address
the possibility that the reduced RgpB(692-702) and
RgpB(D696A) production could result from reduced gene
transcription, the expression levels of rgpB(692-702) and
rgpB(D696A) relative to the control wild-type rgpB gene were
determined. Real-time reverse transcription-PCR of total
RNA preparations showed no significant difference between
the levels of wild-type rgpB positive-control transcript and
rgpB(692-702) and rgpB(D696A) transcripts (results not
FIG. 5. Western blot analyses of protein fractions of the P. gingivalis RgpB(692–702) mutant probed with anti-Rgp. 
, positive control; ,
negative control. Fractions probed with anti-Rgp are indicated as follows: OM, outer membrane; SUP, supernatant; WC, whole cell; PPL,
periplasmic. The arrows indicate the faint 80-kDa band corresponding to precursor RgpB.
FIG. 6. Western blot analyses of protein fractions of P. gingivalis
allele exchange mutants probed with anti-Rgp. Neg and Pos are
the negative and positive controls, respectively. Fractions probed with
anti-Rgp are indicated as follows: 698, RgpB(N698A); 695,
RgpB(F695A); 693, RgpB(T693Q); OM, outer membrane; WC, whole
cell.
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shown). There was no transcript detected in the RgpB nega-
tive-control strain, W50AB-Neg.
DISCUSSION
In the present study, S679, T675, T682, T684, T693, N698,
T724, T728, T730, Y674, and Y718 residues of the RgpB
CTD were selected to screen as potential site(s) of modifi-
cation and membrane attachment. Whole-cell enzyme activ-
ities and Western blot analyses of RgpB with the TSTT
mutation, RgpB(T724Q), RgpB(Y674F), RgpB(Y693F),
and RgpB(Y674F Y718F) in outer membrane fractions
showed the diffuse band of 70 to 90 kDa, as found in the
positive control, indicating surface attachment of the mu-
tated proteins. The lack of obvious change in the attachment
profiles of these mutated RgpBs suggests that these residues
are not essential for secretion or surface attachment of the
protein. Whole-cell enzyme activities and Western blotting
of whole-cell, outer membrane, periplasm, and supernatant
fractions of RgpBs mutated at the conserved residues G699,
G716, and K732 also indicated that the protein was attached
to the cell surface. G699 and G716 were mutated to prolines
in an attempt to perturb the structure of the conserved CTD
regions B and D, respectively. In light of the results, the
proline substitution was not sufficient to abolish the function
of the CTD with respect to secretion and attachment. It was
considered possible that perturbation of the structure of
RgpB CTD may affect the processing/folding of the protein
and, therefore, specific activity of the secreted RgpB. Miko-
lajczyk et al. (17) have demonstrated that sequential auto-
lytic processing of the prodomain and CTD is required for
full specific activity of RgpB, such that changes to the CTD
sequence may affect this sequential autolytic processing.
However, in this current study, substitution of Pro for con-
served Gly residues of the CTD did not affect secretion,
attachment, or activity of RgpB.
In a separate study of the RgpB CTD, the last 13 residues of
the RgpB CTD were truncated in five separate mutants, and
the last five residues were individually mutated to alanines to
investigate the function of the CTD (19). The only common
residue that was targeted in that study (19) and in the current
study was the conserved K732 (K503 in the mature RgpB). In
the current study K732 was targeted to investigate the impor-
tance of this charged residue located only five amino acids
from the C terminus of the CTD. We postulated that the
positive charge of the lysine in close proximity to the C termi-
nus may interact with the negatively charged membrane for
export of RgpB to the surface. The importance of charged
residues involved in sorting of bacterial extracellular proteins
can be seen with the Gram-positive sortases (34). Sortases are
bacterial enzymes responsible for the covalent attachment of
secreted proteins to the cell wall in Gram-positive bacteria.
Proteins destined for sortase-mediated attachment contain an
N-terminal Sec leader and a C-terminal cell wall sorting signal
(CWS) that is characterized by an LPXTG motif, a hydropho-
bic region, and C-terminal positive charge (34). Sortase cleaves
TABLE 3. Mass spectrometric analysis data identifying PG0553
Sample/peptidea Experimentb Mascotscore
Expect
value
W50AB-Neg PMF 73 1.1E04
W50AB-D696A PMF 81 1.9E05
28QISFGGEPLSFSSR41 MS/MS 60 5.5E05
56LTPDFNPEDLIAQSR70 MS/MS 85 1.2E08
119AITLYYDAFNIPEGGR134 MS/MS 71 2.3E07
329SDGLLLQLNDEVPLR343 MS/MS 52 1.8E05
a The identities of the four peptides were independently confirmed by MS/MS
using the negative-control sample. All peptides matched to within 50 ppm of the
calculated mass.
b PMF experiments were conducted on the 63-kDa bands excised from the blot
shown in Fig. 7A.
FIG. 7. Western blot analyses of clarified and concentrated supernatant proteins of P. gingivalis allele exchange mutants probed with anti-Rgp.
(A) The SDS-PAGE gel stained with Coomassie blue. (B) The corresponding Western blot. Pos, positive control (wild-type sequence RgpB); Neg,
negative control. Other recombinant Rgp proteins are indicated by their mutations. The arrow indicates the abundant PG0553 which is found in
the D696A and negative control.
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the CWS motif between the threonine-glycine bond and sub-
sequently catalyzes the transpeptidation of the threonine car-
bonyl to an amine of a pentaglycine cross-bridge, tethering the
C terminus of the protein to the bacterial cell wall (2). Muta-
tional analysis of the two positive residues positioned only a
few residues from the C terminus of the CWS in staphylococcal
protein A showed that this positive charge is required for
retention of the polypeptide within the secretory pathway (34).
In the current study, the conserved RgpB Lys732 was mu-
tated to glutamine, which is the most structurally similar un-
charged residue to lysine, to remove charge but maintain in-
tegrity of the polar structure. The RgpB(K732Q) mutant
exhibited Arg-specific amidolytic activity and a Western blot
profile similar to that of the positive-control strain, with the
presence of the modified 70- to 90-kDa RgpB in outer mem-
brane fractions. These results differ from those observed pre-
viously (19) with an RgpB(K732A) mutant, where mutation of
Lys732 to an Ala resulted in an accumulation of two distinct
bands of approximately 65 and 52 kDa in the periplasm, in
addition to the modified 70- to 90-kDa form of RgpB in the
outer membrane fraction, albeit at lower intensity than that of
the positive control (19). Further, the K732A mutant showed
smaller amounts of active enzyme (54% compared to the pos-
itive control). These results of smaller amounts of attached
RgpB suggest a problem with secretion in this mutant (19).
Alanine is a small amino acid with aliphatic hydrophobic prop-
erties, which differ significantly from lysine, which has a large
side chain and positive charge. Collectively, the results indicate
that the positive charge of K732 is not essential for export or
attachment of RgpB to the outer membrane; however, it ap-
pears that the lysine, possibly because of its polarity and/or the
bulk of its side chain, may be important for proper recognition
by the secretion system.
The most significant change in RgpB surface attachment in
the site-directed mutants was observed with the D696A muta-
tion, where the conserved Asp696 was mutated to Ala. West-
ern blot analyses revealed that Rgp(D696A) could not be de-
tected in whole cells or in any fraction (periplasm, inner
membrane, and outer membrane) of the cell or supernatant.
As the levels of rgpB transcript in W50-D696A and W50AB-
Pos did not differ, and as the RgpB(D696A) precursor could
not be detected in the periplasm or culture fluid of the mutant,
these findings suggest that the protein may be blocked in the
secretion apparatus, which results in the downregulation of
translation and/or the upregulation of proteolysis.
Removal of the RgpB CTD motif B that contains Asp696
resulted in a trace amount of unprocessed precursor being
detected in the outer membrane fraction of the bacterium but
no detection of the protein in any other fraction, including the
periplasm and culture fluid. The trace levels and the precursor
form of the protein are consistent with the lack of enzyme
activity in any fraction (whole cells, supernatant, clarified su-
pernatant, and periplasm) of the mutant. As transcription was
also not affected in this mutant, it appears that translation of
the RgpB(692–702) protein again may have been downregu-
lated and/or that proteolysis was upregulated due to the pro-
tein being trapped in the outer membrane secretory apparatus.
In both the Asp696Ala mutant and the motif B deletion mu-
tant, RgpB(692–702), a 63-kDa protein was substantially in-
creased in abundance, and analysis of this protein by mass
spectrometry indicated that it was the predicted endopeptidase
PG0553. The high level of abundance of this protein, together
with the possible downregulated translation of the mutated
RgpB proteins (Asp696 and motif B), may account for the
small amount of RgpB protein that could be detected in any
fractions of these mutants relative to that of the wild type.
To investigate a possible link between the PG0553 protein-
ase and cell surface processing of RgpB, an isogenic mutant of
P. gingivalis W50 lacking PG0553 was created. The cell surface
Arg-X amidolytic activity of the pg0553 mutant was not signif-
icantly different from that of the control. Further, the cell
surface-attached isoform (70 to 90 kDa) of RgpB was present
in the pg0553 mutant, suggesting that PG0553 does not have an
essential role in the processing of RgpB. As PG0553 was also
found substantially increased in abundance in the negative-
control strain W50AB-Neg not expressing either RgpA or
RgpB, as well as in the D696A and 692–702 mutants, it is
possible that the high abundance of PG0553 (a cell surface/
culture fluid protease) may be related to the lack of the RgpA
and RgpB proteases.
The 692–702 deletion mutant and the D696A mutant phe-
notypes were different from those of the RgpB mutants lacking
the entire CTD (35) or the last 2 to 13 C-terminal residues of
the CTD (19) as the latter mutated RgpB proteins accumu-
lated in the periplasm. This can be explained as the CTD
truncated mutants (19, 35) would not be recognized by the
outer membrane secretion system since they lacked the signal
or complete signal for outer member secretion and, hence,
accumulated in the periplasm. The 692–702 deletion mutant
and the D696A mutant still contained the signal for outer
membrane secretion but were unable to be modified (at-
tached) and, hence, became trapped in the secretion system.
These results suggest that regions D plus E (Fig. 1) involving
the last 22 residues of the RgpB CTD act as the recognition
signal for the CTD secretion system, whereas regions B plus C,
involving D696, in motif B are the attachment recognition
sequence. The results further suggest that secretion and at-
tachment of RgpB are coordinated.
With the exception of Asp696, none of the site-directed
mutations performed in this study, including others in motif B,
significantly affected enzyme presentation on the surface of the
bacterium, and so it seems likely that none of these residues
are sites of modification and therefore surface attachment. It
can be concluded, therefore, that Asp696 of motif B is impor-
tant for CTD function. The most likely role of Asp696 and
motif B is in recognition by a protein of the outer membrane
secretion system that cleaves the CTD and/or covalently at-
taches the CTD onto a sugar moiety of its membrane anchor
A-LPS to form the membrane-modified isoform of the protein.
Hence, when Asp696 is missing, the CTD protein cannot be
processed and becomes trapped in the outer membrane secre-
tion system. Asp696 does not appear to be essential as a small
number of CTD proteins have a Ser, Thr, or Asn residue in its
place. This suggests that a small polar residue will fulfill the
role of Asp696 in motif B. For example, PG0553, the endo-
peptidase upregulated in mutants not expressing Rgp enzyme
activity, is a CTD protein with a Ser residue in place of RgpB’s
Asp696 (Fig. 1). Interestingly, PG0553 was found predomi-
nantly as a C-terminally truncated isoform in the culture su-
pernatant of the Rgp mutant strains not expressing Arg-X
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activity. The presence of PG0553 and RgpB in the culture
supernatant without the CTD sequence suggests that cleavage
of the attached CTD sequence may be the mechanism for
release of the surface-attached protein into the culture fluid.
As the entire CTD sequence is missing in the culture super-
natant isoforms, it is tempting to speculate that the cleavage
site of the CTD for ultimate release of the fully processed
protein into the culture fluid may involve region A (Fig. 1).
Localization of proteins to the surface of the cell of Gram-
negative bacteria requires export of the proteins across the
inner membrane, the periplasm, and the outer membrane. Six
types of outer membrane protein export systems have been
identified that fall into two main categories, those dependent
on the Sec translocon in the inner membrane and those inde-
pendent of Sec (1, 15). Proteins that are Sec dependent have
N-terminal sequences that serve as targets for SecB or the
signal recognition particle (SRP) that function to target the
nascent polypeptide chain to the Sec translocon in the inner
membrane (28, 38). After inner membrane transit, passage of
Sec-dependent proteins into or across the outer membrane
involves transport complexes of the type II system (30a), the
chaperone-usher pathway (33), or the type V system, where the
polypeptide facilitates its own export by insertion of the car-
boxyl domain into the outer membrane to form a -barrel pore
in a mechanism referred to as autotransport (13). P. gingivalis
has no proteins with sequence similarity to these known Sec-
dependent, outer membrane export system proteins (42).
Therefore, it appears that the CTD family proteins are ex-
ported across the outer membrane by a new type of transport
system.
The P. gingivalis proteins PorT (32), PG27 (14), and Sov
(30), which have been demonstrated to be required for the
secretion of RgpB, RgpA, and Kgp, share the same bacterial
species distribution as the CTD and appear to be part of a
novel Bacteroidetes-specific secretion system. Recently, Sato et
al. (31) reported a list of 55 proteins that share this same
species distribution and demonstrated the involvement of
some, including PorK, PorL, PorM, PorN, PorP, PorW, and
PorU (PG26) in RgpB, RgpA, and Kgp secretion. The system
was designated the Por secretion system (PorSS), and some of
the proteins of the system are orthologues of gliding motility
proteins of Flavobacterium johnsoniae, thus providing a link
between the novel protein translocation system and a motility
apparatus in the Bacteroidetes phylum (31).
Recently, we have shown in P. gingivalis isogenic mutants
lacking PG27 or PorT that both CTD proteins and A-LPS
accumulate in the periplasm, indicating that secretion and at-
tachment of the CTD protein to the A-LPS anchor are coor-
dinated (Y.-Y. Chen, B. Peng, M. D. Glew, et al., submitted for
publication). The results of the current study with RgpB also
suggest that secretion and attachment are coordinated. This
coordination could be achieved by the secretion of the CTD
protein and translocation of the A-LPS being linked through
the covalent attachment of the CTD or cleaved CTD to the
A-LPS anchor. Given the range and extent of the mutations
performed in this study, in particular all the conserved residues
of the CTD, the results suggest that the Ser/Thr/Tyr/Asn res-
idues of the RgpB CTD domain are not the sites of modifica-
tion and surface attachment. It seems likely that the CTD acts
as a site of recognition by a P. gingivalis processing enzyme(s),
possibly a novel sortase-like enzyme that cleaves the CTD
sequence and attaches the C-terminal carbonyl to a sugar
amine of A-LPS. Although sortase activity was initially as-
cribed to Gram-positive microorganisms only, more recently,
sortase homologues have been identified in Gram-negative
bacteria (12, 22, 23). Organisms can contain several sortase-
like proteins in their genomes (23), and the level of sequence
identity is low for orthologous proteins (25%), making iden-
tification difficult (23). Further research is required to identify
the protein(s) involved in the coordinated secretion and cell
surface attachment of the CTD proteins. In conclusion, the
results of the current study show that the CTD motif B con-
taining Asp696 is involved in the cell surface attachment of
RgpB in P. gingivalis and that without attachment secretion of
the protein does not occur.
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